Zelira Therapeutics Ltd (ASX: ZLD) Share Price and News

Mr Slate provides accounting and secretarial advice to private and public companies. He has over 15 years' experience in chartered accounting.

Mr Osagie Imasogie has over 30 years of experience in law, finance, business management, healthcare, and the pharmaceutical industry. He is co-founder and Senior Managing Partner of PIPV Capital, a Private Equity firm focused on the Life Sciences sector. Prior to co-founding PIPV Capital, he conceptualized and established GlaxoSmithKline Ventures and was its founding Vice President. He has held senior legal, commercial, and R&D positions at pharmaceutical companies including GSK, SmithKline, DuPont Merck, and Endo, where he was founding General Counsel and Senior Vice President for Corporate Development.

Dr Odumosu was Ilera Healthcare's first Chief Operating Officer, leading the design, implementation, and management of Ilera's business operations following its license award in 2017. He oversaw day-to-day operations of Ilera's vertically integrated grower/processor, wholesale, and dispensary and led the formulation of Ilera's proprietary cannabinoid-based product.

Mr Blake has led the strategic development and commercialisation of several products across various therapeutic categories. He has nearly 20 years of experience in healthcare, building a foundation of knowledge across marketing and the commercial value chain. His work with Rhythm Biosciences as General Manager led the company through the establishment of the pre-launch critical pathway and commercialisation planning for both domestic and international markets.

Dr O'Donnell has led a diverse career in healthcare, life sciences, and public service focused in the Greater Philadelphia area. She was formerly a principal with O'Donnell Associates, working with clients including non-profit organisations, universities, and life science companies such as Cephalon Pharmaceuticals.